BDBM247111 3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-methoxy-N-(2-morpholinoethyl)benzamide::US9701670, 56

SMILES: COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1

InChI Key: InChIKey=TYBHAECIGHGJDF-UHFFFAOYSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 247111   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM247111 (3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-27(2)37-26-39(52(50-37)32-11-10-28(3)29(4)22-32)48-43(54)47-36-12-13-38(35-9-7-6-8-34(35)36)57-40-14-15-45-42(49-40)46-31-23-30(24-33(25-31)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 (Homo sapiens (Human))	BDBM247111 (3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-27(2)37-26-39(52(50-37)32-11-10-28(3)29(4)22-32)48-43(54)47-36-12-13-38(35-9-7-6-8-34(35)36)57-40-14-15-45-42(49-40)46-31-23-30(24-33(25-31)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.30E+4	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level o...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM247111 (3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-27(2)37-26-39(52(50-37)32-11-10-28(3)29(4)22-32)48-43(54)47-36-12-13-38(35-9-7-6-8-34(35)36)57-40-14-15-45-42(49-40)46-31-23-30(24-33(25-31)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against Syk enzymes (Invitrogen), are evaluated in a similar fashion to that described herein...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM247111 (3-((4-((4-(3-(1-(3,4-dimethylphenyl)-3-isopropyl-1...) Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)c(C)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1 Show InChI InChI=1S/C43H47N9O5/c1-27(2)37-26-39(52(50-37)32-11-10-28(3)29(4)22-32)48-43(54)47-36-12-13-38(35-9-7-6-8-34(35)36)57-40-14-15-45-42(49-40)46-31-23-30(24-33(25-31)55-5)41(53)44-16-17-51-18-20-56-21-19-51/h6-15,22-27H,16-21H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				US Patent US9701670 (2017) BindingDB Entry DOI: 10.7270/Q2JM2CP2
					More data for this Ligand-Target Pair